C. Kittel

发表

Influenza B mutant viruses with truncated NS1 proteins grow efficiently in Vero cells and are immunogenic in mice.

T. Popow-Kraupp, T. Muster, T. Wolff, 2009, The Journal of general virology.

Immunogenicity and Protection Efficacy of Replication-Deficient Influenza A Viruses with Altered NS1 Genes

H. Katinger, B. Ferko, J. Romanova, 2004, Journal of Virology.

A genetically adjuvanted influenza B virus vector increases immunogenicity and protective efficacy in mice

T. Muster, M. Wolschek, M. Stukova, 2015, Archives of Virology.

Generation of an Influenza A Virus Vector Expressing Biologically Active Human Interleukin-2 from the NS Gene Segment

H. Katinger, B. Ferko, G. Stiegler, 2005, Journal of Virology.

Live Attenuated Influenza Virus Expressing Human Interleukin-2 Reveals Increased Immunogenic Potential in Young and Aged Hosts

H. Katinger, B. Ferko, J. Romanova, 2006, Journal of Virology.

Live Attenuated Inﬂuenza Virus Expressing Human Interleukin-2 Reveals Increased Immunogenic Potential in Young and Aged Hosts (cid:1)

H. Katinger, B. Ferko, J. Romanova, 2006 .

Development of a live-attenuated influenza B DeltaNS1 intranasal vaccine candidate.

D. Voss, J. Humer, T. Muster, 2009, Vaccine.

Influenza Virus NS Vectors Expressing the Mycobacterium tuberculosis ESAT-6 Protein Induce CD4+ Th1 Immune Response and Protect Animals against Tuberculosis Challenge

H. Katinger, B. Ferko, M. Stukova, 2006, Clinical and Vaccine Immunology.

Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein.

H. Katinger, B. Ferko, M. Stukova, 2006, Tuberculosis.

Optimization of baculovirus transduction on freestyleTM293 cells for the generation of influenza B/Lee/40

W. Ernst, R. Grabherr, S. Nakowitsch, 2006, Molecular biotechnology.

Generation of recombinant influenza virus using baculovirus delivery vector.

W. Ernst, R. Grabherr, A. Egorov, 2003, Journal of virological methods.

Establishment of a Chimeric, Replication-Deficient Influenza A Virus Vector by Modulation of Splicing Efficiency

T. Muster, M. Wolschek, M. Bergmann, 2010, Journal of Virology.

Identification of a novel exon encoding the amino-terminus of the predominant caspase-5 variants.

M. Mildner, L. Eckhart, F. Gruber, 2006, Biochemical and biophysical research communications.

Identification and Characterization of a Novel Mammalian Caspase with Proapoptotic Activity*

L. Eckhart, M. Buchberger, C. Ballaun, 2005, Journal of Biological Chemistry.

Caspase-15 is autoprocessed at two sites that contain an aspartate residue in the P1' position.

L. Eckhart, C. Ballaun, E. Tschachler, 2006, Biochemical and biophysical research communications.

DNA prime/protein boost immunization against HIV clade C: safety and immunogenicity in mice.

Shiu-Lok Hu, R. Ruprecht, J. McKenna, 2006, Vaccine.

The proton translocation domain of cellular vacuolar ATPase provides a target for the treatment of influenza A virus infections

X. Saelens, C. Muller, K. El Bakkouri, 2011, British journal of pharmacology.

Rescue of influenza virus expressing GFP from the NS1 reading frame.

H. Katinger, B. Ferko, J. Romanova, 2004, Virology.

Influenza A mutant viruses with altered NS1 protein function provoke caspase-1 activation in primary human macrophages, resulting in fast apoptosis and release of high levels of interleukins 1beta and 18.

Julia Romanova, Hermann Katinger, H. Katinger, 2005, The Journal of general virology.

Corrigendum to “DNA prime/protein boost immunization against HIV clade C: Safety and immunogenicity in mice” [Vaccine 24 (2006) 2324–2332]

Shiu-Lok Hu, R. Ruprecht, J. McKenna, 2006 .